Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Rodriguez Poncelas, Antonio ^a,b   Garre Olmo, Josep ^b   Franch Nadal, Josep ^c,d   Diez Espino, Javier ^e   Mundet Tuduri, Xavier ^d,f   Barrot De La Puente, Joan ^g   Coll De Tuero, Gabriel ^a,b  

^a EAP Anglès   (Spain)

^b Unitat de Recerca IAS ^*  (Spain)

^c EAP Raval Sud   (Spain)

^d Unitat de Recerca Jordi Gol   (Spain)

^e EAP de Tafalla   (Spain)

^f EAP El Carmel   (Spain)

^g EAP Salt   (Spain)

Author keywords

Albuminuria; Chronic kidney disease; Cross sectional study; Renal impairment; Type 2 diabetes mellitus

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ANAMNESIS; ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONSULTATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT INFORMATION; PHYSICAL EXAMINATION; PREVALENCE; PRIMARY MEDICAL CARE; SEX RATIO; SPAIN; SYSTOLIC BLOOD PRESSURE; URINE ALBUMIN CREATININE RATIO;

AGED; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; PREVALENCE; PRIMARY HEALTH CARE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SPAIN;

EID: 84874077630     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-46     Document Type: Article

References (37)

1. Chronic kidney disease as a global public health problem: approaches and initiatives-a position statement from kidney disease improving global outcomes. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Kidney Int 2007 72 247 259 10.1038/sj.ki.5002343 17568785 (Pubitemid 47172384)
2. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, Circulation 2003 108 2154 2169 10.1161/01.CIR.0000095676. 90936.80 14581387 (Pubitemid 37337595)
3. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY, N Engl J Med 2004 351 1296 1305 10.1056/NEJMoa041031 15385656 (Pubitemid 39268908)
4. Chronic kidney disease: effects on the cardiovascular system. Schiffrin EL, Lipman ML, Mann JF, Circulation 2007 116 85 97 10.1161/CIRCULATIONAHA.106. 678342 17606856 (Pubitemid 47016250)
5. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Chronic Kidney Disease Prognosis Consortium, Lancet 2010 375 2073 2081 20483451
6. US renal data system 2010 annual data report. Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, Am J Kidney Dis 2011 57 1 Suppl 1 8 e1-526 21184928
7. Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective. Laliberté F, Bookhart BK, Vekeman F, Corral M, Duh MS, Bailey RA, J Manag Care Pharm 2009 15 312 322 19422271
8. Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area. Coll-de-Tuero G, Mata-Cases M, Rodriguez-Poncelas A, Pepió JM, Roura P, Benito B, Franch-Nadal J, Saez M, BMC Nephrol 2012 13 1 87 10.1186/1471-2369-13-87 22905926
9. Clinical and laboratory profile of patients with type 2 diabetes with low glomerular filtration rate and normoalbuminuria. Kramer CK, Leitão CB, Pinto LC, Silveiro SP, Gross JL, Canani LH, Diabetes Care 2007 30 1998 2000 10.2337/dc07-0387 17468344 (Pubitemid 47219407)
10. National kidney foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002 39 2 Suppl 1 1 S266 11904577
11. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Ann Intern Med 2006 145 247 254 16908915 (Pubitemid 46768608)
12. Prevalence of renal involvement in a population of type II diabetics followed up in primary care. Marín R, Coca A, Tranche S, Rodríguez Mañas L, Abellán J, Moyá A, Nefrologia 2002 22 152 161 12085416
13. Prevalence of "hidden" renal failure in the population suffering from type-2 diabetes. Tranche Iparraguirre S, Riesgo García A, Marín Iranzo R, Díaz González G, García Fernández A, Aten Primaria 2005 35 359 364 10.1157/13074294 15871797 (Pubitemid 40834557)
14. Prevalence of occult chronic kidney disease and associated variables in a population of patients with type 2 diabetes. Rodríguez-Poncelas A, Quesada Sabate M, Coll De Tuero G, Caula Ros J, Gelada-Batlle E, Gómez-Marcos MA, Med Clin (Barc) 2010 134 239 245 10.1016/j.medcli.2009. 06.069
15. En representación del grupo de investigadores DIABIR. Estimated prevalence of chronic renal failure among patients with type 2 diabetes in Spain. de Pablos-Velasco PL, Ampudia-Blasco FJ, Cobos A, Bergoñón S, Pedrianes P, Med Clin (Barc) 2010 134 340 345 10.1016/j.medcli.2009.09.045
16. Prevalence of chronic kidney disease in patients with type 2 diabetes mellitus treated in primary care. Lou Arnal LM, Campos Gutiérrez B, Cuberes Izquierdo M, Gracia García O, Turón Alcaine JM, Bielsa García S, Nefrologia 2010 30 552 556 20882094
17. Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain). Vinagre I, Mata-Cases M, Hermosilla E, Morros R, Fina F, Rosell M, Castell C, Franch-Nadal J, Bolíbar B, Mauricio D, Diabetes Care 2012 35 774 779 10.2337/dc11-1679 22344609
18. Chronic kidney disease in patients with diabetes mellitus type 2 or hypertension in general practice. van der Meer V, Wielders HP, Grootendorst DC, de Kanter JS, Sijpkens YW, Assendelft WJ, Br J Gen Pract 2010 60 884 890 10.3399/bjgp10X544041 21144198
19. Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice. New JP, Middleton RJ, Klebe B, Farmer CK, de Lusignan S, Stevens PE, Diabet Med 2007 24 364 369 10.1111/j.1464-5491.2007.02075.x 17335468 (Pubitemid 46452394)
20. The chronic kidney disease epidemiology collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the modification of diet in renal disease (MDRD) study formula in subjects with type 2 diabetes. Pugliese G, Solini A, Bonora E, Orsi E, Zerbini G, Giorgino F, Cavalot F, Pontiroli AE, Baroni MG, Morano S, Nicolucci A, Penno G, Atherosclerosis 2011 218 194 199 10.1016/j.atherosclerosis.2011.04.035 21612781
21. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. Penno G, Solini A, Bonora E, Fondelli C, Orsi E, Zerbini G, Trevisan R, Vedovato M, Gruden G, Cavalot F, Cignarelli M, Laviola L, Morano S, Nicolucci A, Pugliese G, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group, J Hypertens 2011 29 1802 1809 10.1097/HJH.0b013e3283495cd6 21738053
22. Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Plantinga LC, Crews DC, Coresh J, Miller ER, Saran R, Yee J, Clin J Am Soc Nephrol 2010 5 673 682 10.2215/CJN.07891109 20338960
23. The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study). Thomas MC, Weekes AJ, Broadley OJ, Cooper ME, Mathew TH, Med J Aust 2006 185 140 144 16893353 (Pubitemid 44262796)
24. Comparison of the prevalence of chronic kidney disease in Japanese patients with Type 1 and Type 2 diabetes. Ohta M, Babazono T, Uchigata Y, Iwamoto Y, Diabet Med 2010 27 1017 1023 10.1111/j.1464-5491.2010.03049.x 20722675
25. Prevalence and risk factors of diabetic nephropathy among Thai patients with type 2 diabetes mellitus. Krairittichai U, Potisat S, Jongsareejit A, Sattaputh C, J Med Assoc Thai 2011 94 Suppl 2 1 S5 22619900
26. Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS). Jia W, Gao X, Pang C, Hou X, Bao Y, Liu W, Nephrol Dial Transplant 2009 24 3724 3731 10.1093/ndt/gfp349 19617258
27. How does minor renal dysfunction influence cardiovascular risk and the management of cardiovascular disease? Pinkau T, Hilgers KF, Veelken R, Mann JF, J Am Soc Nephrol 2004 15 517 523 10.1097/01.ASN.0000107565.17553.71 14978153 (Pubitemid 38294781)
28. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, J Am Soc Nephrol 2004 15 1307 1315 10.1097/01.ASN.0000123691.46138.E2 15100371 (Pubitemid 38526012)
29. All-cause and cardiovascular mortality in diabetic subjects increases significantly with reduced estimated glomerular filtration rate (eGFR): 10 years'data from the south tees diabetes mortality study. Nag S, Bilous R, Kelly W, Jones S, Roper N, Connolly V, Diabet Med 2007 24 10 17 10.1111/j.1464-5491. 2007.02023.x 17227319 (Pubitemid 46103066)
30. The association of microalbuminuria and mortality in non-insulin- dependent diabetes mellitus. A systematic overview of the literature. Dinneen SF, Gerstein HC, Arch Intern Med 1997 157 1413 1418 10.1001/archinte.1997. 00440340025002 9224218 (Pubitemid 27300386)
31. Considerations about the threshold value of microalbuminuria in patients with diabetes mellitus: lessons from an 8-year follow-up study of 599 patients. Rachmani R, Levi Z, Lidar M, Slavachevski I, Half-Onn E, Ravid M, Diabetes Res Clin Pract 2000 49 187 194 10.1016/S0168-8227(00)00155-8 10963831 (Pubitemid 30665465)
32. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, JAMA 2001 286 421 426 10.1001/jama.286.4.421 11466120 (Pubitemid 32681484)
33. Effect of a multifactorial intervention on mortality in type 2 diabetes. Gaede P, Lund-Andersen H, Parving HH, Pedersen O, N Engl J Med 2008 358 580 591 10.1056/NEJMoa0706245 18256393 (Pubitemid 351214285)
34. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Hallan S, Astor B, Romundstad S, Aasarød K, Kvenild K, Coresh J, Arch Intern Med 2007 167 2490 2496 10.1001/archinte.167.22.2490 18071172 (Pubitemid 350254909)
35. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Astor BC, Hallan SI, Miller ER, Yeung E, Coresh J, Am J Epidemiol 2008 167 1226 1234 10.1093/aje/kwn033 18385206 (Pubitemid 351670638)
36. High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the national health and nutrition examination survey 1999-2000. O'Hare AM, Glidden DV, Fox CS, Hsu CY, Circulation 2004 109 320 323 10.1161/01.CIR.0000114519.75433.DD 14732743 (Pubitemid 38133897)
37. Combined role of reduced estimated glomerular filtration rate and microalbuminuria on the prevalence of peripheral arterial disease. Baber U, Mann D, Shimbo D, Woodward M, Olin JW, Muntner P, Am J Cardiol 2009 104 1446 1451 10.1016/j.amjcard.2009.06.068 19892066